- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03687619
Cognitive Orientation to Daily Occupational Performance and Conductive Education Approaches on Down Syndrome
The Effects of Cognitive Orientation to Daily Occupational Performance and Conductive Education Approaches on Fine Motor Skills, Activity and Participation Limitations in Children With Down Syndrome: Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Down syndrome (DS) is a chromosomal anomaly characterized by the presence of an extra copy of genetic material on the 21st chromosome. Sensory, motor, cognitive and perceptual impairments can be seen in children with DS. These impairments probably affect the development and learning of their various fundamental and complex actions. Those children experience decreased motor proficiency, reduced social participation and lower life quality.
Fine motor skills are important for children's everyday functioning such as dressing, feeding, bathing, holding objects, cutting etc. In addition, fine motor skills are related to cognitive, social and academic abilities in children.
This study will be conducted to investigate and compare the effects of Cognitive Orientation to Daily Occupational Performance (CO-OP) and Conductive Education (CE) on fine motor skills, activity, and participation limitations in children with DS. Children with DS aged 7-18 years will be included.
Random allocation software will be used to assign CO-OP or CE to participants. Both CO-OP and CE interventions will last 12 weeks and be conducted for 2 sessions per week. Both intervention will be applied as groups including 3-4 children. Following 12-week wash-out period, interventions will be changed for each group. Two meetings before and during the study will be done in order to inform parents about the interventions and their effects. Another investigator who is blind about the groups will conduct the assessments before and after both first and second treatment durations so 4 assessments will be done in total. At the end of whole treatment schedule, a satisfaction form will be asked from the parents for feedback about both interventions.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Famagusta, Cyprus, 99628
- Eastern Mediterranean University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children aged between 7 and 18 years
- Children who can understand cognitive skills given and can verbally communicate
- Children who can specify at least 3 activities
- Children who have adequate motivation
Exclusion Criteria:
- Caregivers or parents who have inadequate cognitive levels for the study progression
- Children who participate in any physiotherapy/ergo-therapy schedules for at least 3 months
- Children who have Cognitive Orientation to daily Occupational Performance and Conductive Education program.
- Children who have other neurological problems (except Down Syndrome)
- Children who have undergone orthopedic surgery related to upper limbs
- Children who have other health and behavioral problems which can affect the participation in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CO-OP
Cognitive Orientation to daily Occupational Performance (CO-OP) is a top-down approach.
This programme will be conducted as a small group.
Each group will averagely have 5 children.
The primary investigator will conduct the programmes.
It will be one hour session, twice a week, 12 weeks.
|
Interventions (from top to down) related to the development of fine-motor skills
|
Experimental: Conductive Education
Conductive Education is a down-top approach.
This programme will be conducted as a small group.
Each group will averagely have 5 children.
The primary investigator will conduct the programmes.
It will be one hour session, twice a week, 12 weeks.
|
Interventions (from down to top) related to the development of fine-motor skills
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
performance quality rating scale
Time Frame: 12 weeks
|
The PQRS rates performance quality on a 10-point scale, with a score of 1 indicating ''can't do the skill at all'' and 10 indicating ''does the skill very well''.
An independent observer rates performances from video recorded trials of each skill at all assessment points.
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Nine Hole Peg Test
Time Frame: 12 weeks
|
The Nine-Hole Peg Test is a timed dexterity test that evaluates the ability to pick up nine 1¼-inch-long plastic pegs from a shallow dish, place them one at a time into a pegboard, and remove them one at a time back into the dish.
The total time to complete the task for each hand will be recorded in seconds.
|
12 weeks
|
Bruininks-Oseretsky Motor Proficiency Test - Brief Form
Time Frame: 12 weeks
|
It will be used to determine the motor skills of the children.
Bilateral coordination, balance, strength and speed-agility will be measured to specify gross motor skills, while fine motor precision, fine motor integration, manual dexterity, and upper limb coordination will be measured for fine motor skills.
|
12 weeks
|
Canadian Occupational Performance Measure
Time Frame: 12 weeks
|
The COPM is an outcome measure that, through a semi-structured interview, is designed to (a) identify and prioritize occupational performance issues or goals, and (b) measure clients' self perceived changes in occupational performance and satisfaction with their performance over time, of identified goals.
|
12 weeks
|
Dynamic Performance Analysis
Time Frame: 12 weeks
|
DPA is a dynamic, iterative process, carried out as the client performs the occupation.
The purpose of DPA is to identify where performance breaks down and test out solutions.This analysis will be used within the concept of CO-OP.
|
12 weeks
|
Child Health Questionnaire- Parent Form
Time Frame: 12 weeks
|
The CHQ PF-50 is a 50 item, parent-completed questionnaire designed to measure the physical and psychosocial well-being of children with and without chronic conditions.
Reliability and validity of Turkish version have been shown.
The CHQ PF-50 measures components of physical and psychosocial functioning in 12 categories (subscales).
The subscales used for our analyses included: physical functioning, role/social limitations (note: we call this subscale "School & Friends" since it measures the degree to which schoolwork or activities with friends are limited due to problems with physical health), bodily pain/ discomfort, mental health, and self-esteem.
|
12 weeks
|
Goal Attainment Scaling
Time Frame: 12 weeks
|
The goal attainment scale is characterised by five levels of achievement.
The expected outcome is the middle or 'zero' score.
This expected outcome is determined first and then two better and two worse outcomes are documented.
It enables individualised goals to be set and allows measurement of clinically important change which may not be detected by standardised assessments
|
12 weeks
|
Parent Satisfaction Form
Time Frame: 12 weeks
|
It is a semi-structured questionnaire which will indicate the satisfaction level of parents from both approaches.
|
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Emine H. Tüzün, Prof. Dr., Instructor
- Principal Investigator: Hülya Özbeşer, MSc. PT, Instructor
- Principal Investigator: Levent Eker, M. D., Instructor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Disease
- Congenital Abnormalities
- Genetic Diseases, Inborn
- Intellectual Disability
- Abnormalities, Multiple
- Chromosome Disorders
- Chromosome Aberrations
- Aneuploidy
- Chromosome Duplication
- Syndrome
- Down Syndrome
- Trisomy
Other Study ID Numbers
- ETK00-218-0213
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Down Syndrome, Trisomy 21
-
Axis Shield Diagnostics LtdThe Clinical Trial CompanyCompletedTrisomy 21 in Fetus | Trisomy 18 in Fetus | Trisomy 13 in FetusUnited Kingdom
-
University of PennsylvaniaSequenom, Inc/Laboratory Corporation of America HoldingsCompleted
-
BioCeryxUniversity of British Columbia; University College London Hospitals; Brugmann... and other collaboratorsUnknownTrisomy 21 and Other Fetal AneuploidyAustralia, United Kingdom, Spain, Canada, Belgium, Portugal
-
Assistance Publique - Hôpitaux de ParisCompletedTrisomy 21 - TranslocationFrance
-
Boston Children's HospitalCompleted
-
Assistance Publique - Hôpitaux de ParisCompletedTrisomy 21, 18 and 13 ScreeningFrance
-
Natera, Inc.CompletedTrisomy 21 | Trisomy 18 | Trisomy 13 | Vanishing TwinUnited States
-
Cindy CisnerosCompletedDown Syndrome | Aneuploidy | Trisomy 21 | Trisomy 18 | Trisomy 13United States
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR); Laval University; Genome British... and other collaboratorsCompletedTrisomy 21 | Trisomy 18 | Trisomy 13Canada
-
PerkinElmer, Wallac OyAzienda Ospedaliera Città della Salute e della Scienza di TorinoUnknownTrisomy 21 | Trisomy 18 | Trisomy 13Italy
Clinical Trials on CO-OP
-
Federal University of Minas GeraisCompletedAttention Deficit and Disruptive Behavior Disorders | Motor Skills DisordersBrazil
-
Hopitaux de Saint-MauriceInstitut National de la Santé Et de la Recherche Médicale, France; Ministry... and other collaboratorsCompleted
-
University Hospital, ToulouseTerminatedCerebrovascular AccidentFrance
-
Hopitaux de Saint-MauriceCompletedAcquired Brain InjuryFrance
-
University of British ColumbiaWaterloo FoundationUnknown
-
ZEYNEP KOLİTCompletedCerebral Palsy | Cognitive OrientationTurkey
-
Sunnybrook Health Sciences CentreUniversity Health Network, Toronto; University of Toronto; West Park Healthcare... and other collaboratorsCompleted
-
St. John's Rehab HospitalSunnybrook Health Sciences Centre; Washington University School of Medicine; University...CompletedStrokeUnited States, Canada
-
Shirley Ryan AbilityLabMidwestern UniversityCompletedCerebral Vascular AccidentUnited States
-
Hacettepe UniversityCompletedCerebral Palsy | Goals | Occupational Problems | Cognitive OrientationTurkey